Tailoring cyclosporine according to kinetic profiles: does it allow a low-dose therapeutic schedule?
Segoloni, G.P.; Triolo, G.; Squiccimarro, G.; Colla, L.; Turello, E.; Aimo, G.; Pecchio, F.; Vercellone, A.
Transplantation Proceedings 19(1 Pt 2): 1726-1727
1987
ISSN/ISBN: 0041-1345 PMID: 3274416 Document Number: 289898
Document emailed within 1 workday
Related Documents
Garsou, J.; Boniver, R. 1971: Distribution of absorbed dose rates around Crowe's applicator. Proposal of a new schedule for therapeutic use Journal Belge de Radiologie 54(6): 701-708Mrowietz, U.; Christophers, E. 1988: Effects of cyclosporine a treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro Transplantation Proceedings 20(3 Suppl 4: 53-57
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
van den Borne, B.E.; Landewé, R.B.; Goei The, H.S.; Rietveld, J.H.; Zwinderman, A.H.; Bruyn, G.A.; Breedveld, F.C.; Dijkmans, B.A. 1998: Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine Journal of Rheumatology 25(8): 1493-1498
Serino, F.; Citterio, F.; Pozzetto, U.; Grevel, J.; Castagneto, M. 1994: Abbreviated three-point kinetic profile in the 12-hour area under the curve for pharmacokinetic monitoring of cyclosporine Transplantation Proceedings 26(5): 2807-2808
Hajjar, E.T.; Wahby, V.; Cortas, N.; Salti, I. 1974: The dose schedule in methimazole treatment of hyperthyroidism Le Journal Medical Libanais. Lebanese Medical Journal 27(1): 99-104
Gnanadesikan, S.; Murthy, K.V.; Vijayakumar, J.; Parasuraman, D. 1975: Evaluation of immune response to single dose schedule of TAB vaccine Indian Journal of Medical Research 63(11): 1577-1582
Giwa-Osagie, O.F.; Savage, J.; Newton, J.R. 1978: Norethisterone oenanthate as an injectable contraceptive: use of a modified dose schedule British Medical Journal 1(6128): 1660-1662
Giwa-Osagie, O.F.; Savage, J.; Newton, J.R. 1978: Norethisterone oenanthate as an injectable contraceptive: use of a modified dose schedule British Medical Journal 1(6128): 1660-1662
Gottlieb, J.A.; Frei, E.; Luce, J.K. 1971: Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma Cancer ChemoTherapy Reports 55(3): 277-280
Landers, P.J. 1972: Therapeutic schedule for diabetic ketoacidosis Die Medizinische Welt 9: 298-300
O'Dwyer, P.J.; Hudes, G.R.; Walczak, J.; Schilder, R.; LaCreta, F.; Rogers, B.; Cohen, I.; Kowal, C.; Whitfield, L.; Boyd, R.A. 1992: Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule Cancer Research 52(24): 6746-6753
Pereira, M.L.; Mendonça, J.S. 1985: Sexually transmitted diseases: therapeutic schedule Amb: Revista da Associacao Medica Brasileira 31(9-10): 207-210
1989: Measles outbreaks prompt pediatrics academy to call for two-dose immunization schedule Clinical Pharmacy 8(11): 760-761
Kerr, I.G.; Zimm, S.; Collins, J.M.; O'Neill, D.; Poplack, D.G. 1984: Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey Cancer Research 44(11): 4929-4932
Elgefors, B.; Lidin-Janson, G.; Svensson, R.; Hansson, O.; Wåhlén, P.; Rosenhall, U.; Stattin, S.; Wasz-Höckert, O. 1983: Tuberculous meningitis--case report and therapeutic schedule Lakartidningen 80(19): 2027-2030
Jain, D.C.; Sethumadhavan, K.V.; Babu, C.S.; Johney, V.M.; Ghosh, T.K. 1988: Practical and effective dose schedule of diethylcarbamazine (DEC) against bancroftian filariasis for mass therapy campaigns Journal of Communicable Diseases 20(1): 61-69
Yoshimura, T.; Hirade, K.; Iihara, H.; Ishihara, M.; Komori, Y.; Okayasu, S.; Matsuura, K.; Yasuda, T.; Itoh, Y. 2008: A retrospective analysis of adverse events based on a dose and a schedule in patients who underwent paclitaxel- containing chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1721-1726
Rienks, A. 2000: Almost-tolerance halves cyclosporine dose Nephrology News and Issues 14(6): 42-43
Rajan, R.; Subhadra, N.M.; Sarada, A.K.; Usha, D.L.; John, R. 1979: Evaluation of a lower dose schedule of intramuscular 15(S)-15-methyl prostaglandin F2 alpha for induction of early midtrimester abortion Journal of Obstetrics and Gynaecology of India 29(1): 38-43